ArticleJournal for immunotherapy of cancer2019

HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.

David M Richards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.